2019
DOI: 10.1016/j.transproceed.2019.08.011
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Myofibroblastic Tumor After Lung Transplant—A Rare and Aggressive Complication: A Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…It is possible that immunosuppression contributed to the development of IMT in this patient. Cases of IMT have been reported in recipients of lung, renal, and stem cell transplants, occurring both during and after receiving intensive immunosuppressive therapy [10][11][12][13]. Harel et al posited a "two-hit hypothesis," where immunosuppression acts as an initial "hit," rendering the individual more vulnerable to subsequent events that promote IMT formation [11].…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that immunosuppression contributed to the development of IMT in this patient. Cases of IMT have been reported in recipients of lung, renal, and stem cell transplants, occurring both during and after receiving intensive immunosuppressive therapy [10][11][12][13]. Harel et al posited a "two-hit hypothesis," where immunosuppression acts as an initial "hit," rendering the individual more vulnerable to subsequent events that promote IMT formation [11].…”
Section: Discussionmentioning
confidence: 99%